Folgen
Martin Götte
Martin Götte
Professor (venia legendi: Medizinische Biochemie) Universitätsklinikum Münster
Bestätigte E-Mail-Adresse bei uni-muenster.de
Titel
Zitiert von
Zitiert von
Jahr
Functions of cell surface heparan sulfate proteoglycans
M Bernfield, M Götte, PW Park, O Reizes, ML Fitzgerald, J Lincecum, ...
Annual review of biochemistry 68 (1), 729-777, 1999
34431999
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages
L Schaefer, A Babelova, E Kiss, HJ Hausser, M Baliova, M Krzyzankova, ...
The Journal of clinical investigation 115 (8), 2223-2233, 2005
10052005
The pathogenesis of endometriosis: molecular and cell biology insights
AS Laganà, S Garzon, M Götte, P Viganò, M Franchi, F Ghezzi, DC Martin
International journal of molecular sciences 20 (22), 5615, 2019
5222019
Syndecans in inflammation
M Götte
The FASEB Journal 17 (6), 575-591, 2003
4492003
Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective
M Gotte, GW Yip
Cancer research 66 (21), 10233-10237, 2006
4462006
Therapeutic value of glycosaminoglycans in cancer
GW Yip, M Smollich, M Gotte
Molecular cancer therapeutics 5 (9), 2139-2148, 2006
3322006
Heparan sulfate structure in mice with genetically modified heparan sulfate production
J Ledin, W Staatz, JP Li, M Götte, S Selleck, L Kjellén, D Spillmann
Journal of Biological Chemistry 279 (41), 42732-42741, 2004
3192004
Vesicular transport: how many Ypt/Rab-GTPases make a eukaryotic cell?
T Lazar, M Götte, D Gallwitz
Trends in biochemical sciences 22 (12), 468-472, 1997
3091997
miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness
M Götte, C Mohr, CY Koo, C Stock, AK Vaske, M Viola, SA Ibrahim, ...
Oncogene 29 (50), 6569-6580, 2010
2682010
Increased expression of the adult stem cell marker Musashi‐1 in endometriosis and endometrial carcinoma
M Götte, M Wolf, A Staebler, O Buchweitz, R Kelsch, AN Schüring, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008
2492008
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling …
SA Ibrahim, R Gadalla, EA El-Ghonaimy, O Samir, HT Mohamed, ...
Molecular cancer 16, 1-19, 2017
2482017
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression
V Nikolova, CY Koo, SA Ibrahim, Z Wang, D Spillmann, R Dreier, ...
Carcinogenesis 30 (3), 397-407, 2009
2152009
Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
E Karousou, S Misra, S Ghatak, K Dobra, M Götte, D Vigetti, A Passi, ...
Matrix Biology 59, 3-22, 2017
2102017
Flow cytometry in cancer stem cell analysis and separation
B Greve, R Kelsch, K Spaniol, HT Eich, M Götte
Cytometry Part A 81 (4), 284-293, 2012
2042012
Targeting of syndecan‐1 by microRNA miR‐10b promotes breast cancer cell motility and invasiveness via a Rho‐GTPase‐ and E‐cadherin‐dependent mechanism
SA Ibrahim, GW Yip, C Stock, JW Pan, C Neubauer, M Poeter, D Pupjalis, ...
International journal of cancer 131 (6), E884-E896, 2012
1842012
Role of syndecan-1 in leukocyte–endothelial interactions in the ocular vasculature
M Götte, AM Joussen, C Klein, P Andre, DD Wagner, MT Hinkes, ...
Investigative ophthalmology & visual science 43 (4), 1135-1141, 2002
1802002
Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
I Radke, M Götte, C Kersting, B Mattsson, L Kiesel, P Wülfing
British journal of cancer 95 (3), 347-354, 2006
1742006
Characterization of endometrial mesenchymal stem-like cells obtained by endometrial biopsy during routine diagnostics
AN Schüring, N Schulte, R Kelsch, A Röpke, L Kiesel, M Götte
Fertility and sterility 95 (1), 423-426, 2011
1692011
Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction
D Vanhoutte, MWM Schellings, M Götte, M Swinnen, V Herias, MK Wild, ...
Circulation 115 (4), 475-482, 2007
1662007
Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers–Danlos syndrome patient carrying the …
DG Seidler, M Faiyaz-Ul-Haque, U Hansen, GW Yip, SHE Zaidi, AS Teebi, ...
Journal of molecular medicine 84, 583-594, 2006
1412006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20